Phosphonic Acid Coupling Agent Modification of HAP Nanoparticles: Interfacial Effects in PLLA/HAP Bone Scaffold

Current research on bone scaffolds faces a challenge in achieving strong interfacial bonding between inorganic and organic components. Hydroxyapatite (HAP) is widely used for its osteoconductive properties, while poly-l-lactic acid (PLLA) is favored for its biodegradability. However, poor adhesion between these materials limits mechanical performance and biological function. Prior studies have explored coupling agents to bridge this gap, but their effectiveness varies. This gap motivated the search for a more reliable chemical strategy. The need for a functionalized interface that enhances mechanical and biological outcomes remains unmet. Researchers have proposed various approaches, yet few address both mechanical and bioactive properties simultaneously. The lack of a dual-function coupling agent has left this area underexplored. This paper introduces a novel approach using phosphonic acid to improve interfacial bonding and scaffold functionality.

The study aimed to enhance the interfacial bonding between HAP and PLLA in bone scaffolds. The specific problem addressed was the weak adhesion between these two materials, which reduces mechanical strength and bioactivity. The motivation came from the need for a scaffold that supports both structural integrity and cellular activity. The researchers proposed using a phosphonic acid coupling agent to modify HAP nanoparticles. This agent was selected for its ability to form strong bonds with both HAP and PLLA. The goal was to fabricate a scaffold with improved mechanical and biological properties. The study focused on the chemical mechanism of interfacial bonding and its effect on scaffold performance. The ultimate aim was to create a more effective bone scaffold for clinical applications.

The researchers used 2-Carboxyethylphosphonic acid (CEPA) to modify HAP nanoparticles. This modification was intended to improve the interaction between HAP and PLLA. The modified HAP was then incorporated into a PLLA matrix. Selective laser sintering was used to fabricate the scaffold. The interfacial bonding mechanism was analyzed using electrovalent and ester bond formation. The mechanical properties of the scaffold were tested using tensile strength and modulus measurements. The scaffold's ability to attract Ca²⁺ was evaluated in simulated body fluid. The release of Ca²⁺ and PO₄³⁻ was monitored to assess bioactivity. The study combined chemical modification, fabrication, and performance testing to evaluate the scaffold's properties.

The modified HAP (C-HAP) showed homogeneous dispersion in the PLLA matrix. The scaffold exhibited an interconnected morphology due to enhanced bonding. Tensile strength increased by 1.40 times compared to the unmodified scaffold. The modulus increased by 2.79 times with 20% C-HAP. The scaffold could attract Ca²⁺ from simulated body fluid, promoting apatite layer formation. The phosphonic acid group facilitated this process through electrovalent bonding. Degradation of the scaffold released Ca²⁺ and PO₄³⁻, supporting cell attachment and growth. The results suggest that the modified scaffold has improved mechanical and bioactive properties.

The study demonstrated that CEPA modification improved interfacial bonding between HAP and PLLA. The enhanced bonding led to better mechanical properties and bioactivity. The scaffold with 20% C-HAP showed significant improvements in tensile strength and modulus. The phosphonic acid group played a key role in attracting Ca²⁺ and forming an apatite layer. The release of Ca²⁺ and PO₄³⁻ supported cell attachment and proliferation. The results suggest that the modified scaffold has potential for bone tissue engineering. The study highlights the importance of chemical modification in improving scaffold performance. The findings may guide future research on functionalized bone scaffolds.